Skip to main content

Memory Disorders

2
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
1
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
1100%
+ 2 programs with unclassified modality

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
1
CelecoxibPhase 3Small Molecule1 trial
Active Trials
NCT00009230CompletedEst. Aug 2005
Pfizer
PfizerNEW YORK, NY
1 program
1
AriceptPhase 21 trial
Active Trials
NCT00031018Unknown
UCB Pharma
UCB PharmaBelgium - Brussels
1 program
PiracetamN/A1 trial
Active Trials
NCT00567060Completed676Est. Jan 2004

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Angeles TherapeuticsCelecoxib
UCB PharmaPiracetam

Clinical Trials (3)

Total enrollment: 676 patients across 3 trials

NCT00009230Angeles TherapeuticsCelecoxib

Anti-Inflammatory Treatment for Age-Associated Memory Impairment: A Double-Blind Placebo-Controlled Trial

Start: Jun 2000Est. completion: Aug 2005
Phase 3Completed
NCT00031018PfizerAricept

Prevention of Cognitive Decline in Alzheimer's Disease by Ingested Interferon Alpha

Phase 2Unknown
NCT00567060UCB PharmaPiracetam

Efficacy and Safety of Piracetam Taken for 12 Months in Subjects Suffering From Mild Cognitive Impairment (MCI)

Start: May 2000Est. completion: Jan 2004676 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.